Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial.
Helget LN, Davis-Karim A, O'Dell JR, Mikuls TR, Newcomb JA, Androsenko M, Brophy MT, England BR, Ferguson R, Pillinger MH, Neogi T, Wu H, Palevsky PM.
Helget LN, et al. Among authors: wu h.
Am J Kidney Dis. 2024 Jun 19:S0272-6386(24)00835-7. doi: 10.1053/j.ajkd.2024.04.017. Online ahead of print.
Am J Kidney Dis. 2024.
PMID: 38906504